These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17500222)

  • 1. [The new combined antituberculous drug: the original combined antituberculous drug dioxazid].
    Glushkov RG; Sokolova GB; Krylova LIu; Stebaeva LF; Sharova SA
    Probl Tuberk Bolezn Legk; 2007; (3):20-5. PubMed ID: 17500222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of tuberculosis patients with massive bacterial excretion].
    Gavril'ev SS; Vinokurova MK
    Probl Tuberk; 1997; (2):17-8. PubMed ID: 9235572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Design and study of new agents having antitubercular activity: the original compound perchlosone as a potent agent of etiotropic therapy for tuberculosis].
    Vinogradova TI; Aleksandrova AE; Antonenkova EV; Elokhina VN; Nakhmanovich AS
    Probl Tuberk; 1999; (3):45-7. PubMed ID: 10420769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Improved technology of chemotherapy of pulmonary tuberculosis complicated by other diseases].
    Gavril'ev SS; Nikolaev VP; Vinokurova MK; Petukhova NIu; Gavril'eva LP; Malogulova ISh
    Probl Tuberk; 2001; (2):8-11. PubMed ID: 11490482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monitoring of chemotherapy in patients with pulmonary tuberculosis by the blood bacteriostatic activity-determining test].
    Manicheva OA; Skvortsova LA; Pavlova MV; Sapozhnikova NV; Archakova LI; Vishnevskiĭ BI
    Probl Tuberk Bolezn Legk; 2008; (5):14-7. PubMed ID: 18711812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An experimental study of the chemotherapeutic efficacy of flurenizid, a new antitubercular pharmaceutical].
    Khomenko AG; Golyshevskaia VI; Maslova LI; Kalmykova GN; Uvarova OA
    Probl Tuberk; 1990; (6):3-7. PubMed ID: 2217100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the efficiency of activity of the liposomal form of isoniazid against different types of mycobacteria in vitro].
    Golyshevskaia VI; Selishcheva AA; Martynova LP; Lepekha LN; Kalashnikova TM; Kornilova ZKh; Erokhin VV; Rozenberg OA
    Probl Tuberk Bolezn Legk; 2006; (8):61-4. PubMed ID: 17002062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN; Barrera L
    Medicina (B Aires); 2007; 67(3):231-7. PubMed ID: 17628909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthesis and tuberculostatic activity of fluoridized 3-Z-hydrazine-2-benzoyl acrylates and their cyclization products].
    Kravcheko MA; Nosova EV; Lipunova GN; Chasovskikh OM; Sokolov VA; Charushin VN
    Probl Tuberk Bolezn Legk; 2003; (7):49-52. PubMed ID: 12939881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.
    Sar B; Keo C; Leng C; Saman M; Min DC; Chan S; Monchy D; Sarthou JL
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):104-7. PubMed ID: 19323041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of efficiency of large and small doses of isoniazid in combined treatment in pulmonary tuberculosis].
    Mysakowska H; Grodzki S; Przemyska B; Szarewicz W; Srednicka D
    Pol Tyg Lek; 1965 Apr; 20(16):562-4. PubMed ID: 5834844
    [No Abstract]   [Full Text] [Related]  

  • 13. [The course of a process and the efficiency of treatment of pulmonary tuberculosis patients excreting Mycobacterium tuberculosis with extensive drug resistance to antituberculous drugs].
    Mishin VIu; Komissarova OG; Chukanov VI; Kononets AS
    Probl Tuberk Bolezn Legk; 2009; (2):50-2. PubMed ID: 19382643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS
    Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preliminary study on isoniazid-epiroprim combination in a tuberculosis murine model].
    N'guessan K; Dosso M; Marchal G; Chavarot P; Romain F; Pescher P; Edy
    Bull Soc Pathol Exot; 2002 Nov; 95(4):265-8. PubMed ID: 12596375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Features of isoniazid activation in patients with tuberculosis and diabetes mellitus].
    Karachunskiĭ MA; Kaminskaia GO; Kossiĭ IuE; Chernykh NA
    Probl Tuberk; 2001; (7):26-7. PubMed ID: 11763557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modern principles for the organization of drug therapy in tuberculosis].
    Bondarev IM
    Bull Int Union Tuberc; 1974; 49(1):234-40. PubMed ID: 4219729
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of treatment in patients with destructive pulmonary tuberculosis without consideration of drug sensitivity in Mycobacterium tuberculosis].
    Abashev IM; Kozlova AI; Ivanova LN
    Probl Tuberk Bolezn Legk; 2008; (1):33-5. PubMed ID: 18318228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on pulmonary tuberculous patients failed to respond to chemotherapy using primary antituberculous drugs.
    Ishiguro S
    Kekkaku; 1968 Feb; 43(2):71-83. PubMed ID: 4971167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.